Literature DB >> 19713934

Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody.

Mickaël V Cherrier1, Bärbel Kaufmann, Grant E Nybakken, Shee-Mei Lok, Julia T Warren, Beverly R Chen, Christopher A Nelson, Victor A Kostyuchenko, Heather A Holdaway, Paul R Chipman, Richard J Kuhn, Michael S Diamond, Michael G Rossmann, Daved H Fremont.   

Abstract

Flaviviruses are a group of human pathogens causing severe encephalitic or hemorrhagic diseases that include West Nile, dengue and yellow fever viruses. Here, using X-ray crystallography we have defined the structure of the flavivirus cross-reactive antibody E53 that engages the highly conserved fusion loop of the West Nile virus envelope glycoprotein. Using cryo-electron microscopy, we also determined that E53 Fab binds preferentially to spikes in noninfectious, immature flavivirions but is unable to bind significantly to mature virions, consistent with the limited solvent exposure of the epitope. We conclude that the neutralizing impact of E53 and likely similar fusion-loop-specific antibodies depends on its binding to the frequently observed immature component of flavivirus particles. Our results elucidate how fusion-loop antibodies, which comprise a significant fraction of the humoral response against flaviviruses, can function to control infection without appreciably recognizing mature virions. As these highly cross-reactive antibodies are often weakly neutralizing they also may contribute to antibody-dependent enhancement and flavi virus pathogenesis thereby complicating development of safe and effective vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19713934      PMCID: PMC2771083          DOI: 10.1038/emboj.2009.245

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  41 in total

1.  Combining electron microscopic with x-ray crystallographic structures.

Authors:  M G Rossmann; R Bernal; S V Pletnev
Journal:  J Struct Biol       Date:  2001-12       Impact factor: 2.867

2.  Structures of immature flavivirus particles.

Authors:  Ying Zhang; Jeroen Corver; Paul R Chipman; Wei Zhang; Sergei V Pletnev; Dagmar Sedlak; Timothy S Baker; James H Strauss; Richard J Kuhn; Michael G Rossmann
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

3.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

4.  Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions.

Authors:  F Guirakhoo; F X Heinz; C W Mandl; H Holzmann; C Kunz
Journal:  J Gen Virol       Date:  1991-06       Impact factor: 3.891

5.  Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins.

Authors:  Shee-Mei Lok; Victor Kostyuchenko; Grant E Nybakken; Heather A Holdaway; Anthony J Battisti; Soila Sukupolvi-Petty; Dagmar Sedlak; Daved H Fremont; Paul R Chipman; John T Roehrig; Michael S Diamond; Richard J Kuhn; Michael G Rossmann
Journal:  Nat Struct Mol Biol       Date:  2008-02-10       Impact factor: 15.369

6.  Induction of epitope-specific neutralizing antibodies against West Nile virus.

Authors:  Theodore Oliphant; Grant E Nybakken; S Kyle Austin; Qing Xu; Jonathan Bramson; Mark Loeb; Mark Throsby; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

7.  Differentiation of West Nile and St. Louis encephalitis virus infections by use of noninfectious virus-like particles with reduced cross-reactivity.

Authors:  Jill A Roberson; Wayne D Crill; Gwong-Jen J Chang
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

Review 8.  Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses.

Authors:  Douglas G Widman; Ilya Frolov; Peter W Mason
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

9.  Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation.

Authors:  Stéphane Bressanelli; Karin Stiasny; Steven L Allison; Enrico A Stura; Stéphane Duquerroy; Julien Lescar; Franz X Heinz; Félix A Rey
Journal:  EMBO J       Date:  2004-02-12       Impact factor: 11.598

10.  Structural basis of West Nile virus neutralization by a therapeutic antibody.

Authors:  Grant E Nybakken; Theodore Oliphant; Syd Johnson; Stephen Burke; Michael S Diamond; Daved H Fremont
Journal:  Nature       Date:  2005-09-29       Impact factor: 49.962

View more
  112 in total

1.  Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles.

Authors:  Jiraphan Junjhon; Thomas J Edwards; Utaiwan Utaipat; Valorie D Bowman; Heather A Holdaway; Wei Zhang; Poonsook Keelapang; Chunya Puttikhunt; Rushika Perera; Paul R Chipman; Watchara Kasinrerk; Prida Malasit; Richard J Kuhn; Nopporn Sittisombut
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

2.  Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice.

Authors:  Juergen Zlatkovic; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

3.  Refinement and Analysis of the Mature Zika Virus Cryo-EM Structure at 3.1 Å Resolution.

Authors:  Madhumati Sevvana; Feng Long; Andrew S Miller; Thomas Klose; Geeta Buda; Lei Sun; Richard J Kuhn; Michael G Rossmann
Journal:  Structure       Date:  2018-06-26       Impact factor: 5.006

4.  The infectivity of prM-containing partially mature West Nile virus does not require the activity of cellular furin-like proteases.

Authors:  Swati Mukherjee; Tsai-Yu Lin; Kimberly A Dowd; Carolyn J Manhart; Theodore C Pierson
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

5.  A fusion-loop antibody enhances the infectious properties of immature flavivirus particles.

Authors:  Izabela A Rodenhuis-Zybert; Bastiaan Moesker; Júlia M da Silva Voorham; Heidi van der Ende-Metselaar; Michael S Diamond; Jan Wilschut; Jolanda M Smit
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

Review 6.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

7.  Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres.

Authors:  Pavel Plevka; Anthony J Battisti; Jiraphan Junjhon; Dennis C Winkler; Heather A Holdaway; Poonsook Keelapang; Nopporn Sittisombut; Richard J Kuhn; Alasdair C Steven; Michael G Rossmann
Journal:  EMBO Rep       Date:  2011-05-13       Impact factor: 8.807

8.  Advanced oxidation technology for the development of a next-generation inactivated West Nile virus vaccine.

Authors:  Benjamin K Quintel; Archana Thomas; Danae E Poer DeRaad; Mark K Slifka; Ian J Amanna
Journal:  Vaccine       Date:  2018-12-31       Impact factor: 3.641

9.  The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.

Authors:  Bimmi Shrestha; James D Brien; Soila Sukupolvi-Petty; S Kyle Austin; Melissa A Edeling; Taekyung Kim; Katie M O'Brien; Christopher A Nelson; Syd Johnson; Daved H Fremont; Michael S Diamond
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

10.  Immature dengue virus: a veiled pathogen?

Authors:  Izabela A Rodenhuis-Zybert; Hilde M van der Schaar; Júlia M da Silva Voorham; Heidi van der Ende-Metselaar; Huan-Yao Lei; Jan Wilschut; Jolanda M Smit
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.